These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3172121)

  • 1. Isoprenoid (phosphinylmethyl)phosphonates as inhibitors of squalene synthetase.
    Biller SA; Forster C; Gordon EM; Harrity T; Scott WA; Ciosek CP
    J Med Chem; 1988 Oct; 31(10):1869-71. PubMed ID: 3172121
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoprenyl phosphinylformates: new inhibitors of squalene synthetase.
    Biller SA; Forster C; Gordon EM; Harrity T; Rich LC; Marretta J; Ciosek CP
    J Med Chem; 1991 Jun; 34(6):1912-4. PubMed ID: 2061928
    [No Abstract]   [Full Text] [Related]  

  • 3. Squalene synthetase. Stoichiometry and kinetics of presqualene pyrophosphate and squalene synthesis by yeast microsomes.
    Agnew WS; Popják G
    J Biol Chem; 1978 Jul; 253(13):4566-73. PubMed ID: 26684
    [No Abstract]   [Full Text] [Related]  

  • 4. 1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate.
    Magnin DR; Biller SA; Dickson JK; Logan JV; Lawrence RM; Chen Y; Sulsky RB; Ciosek CP; Harrity TW; Jolibois KG
    J Med Chem; 1995 Jul; 38(14):2596-605. PubMed ID: 7629799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squalene synthetase.
    Agnew WS
    Methods Enzymol; 1985; 110():359-73. PubMed ID: 3894879
    [No Abstract]   [Full Text] [Related]  

  • 6. Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents.
    Cohen LH; Valentijn AR; Roodenburg L; Van Leeuwen RE; Huisman RH; Lutz RJ; Van der Marel GA; Van Boom JH
    Biochem Pharmacol; 1995 Mar; 49(6):839-45. PubMed ID: 7702642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific synthesis and biological evaluation of farnesyl diphosphate isomers.
    Shao Y; Eummer JT; Gibbs RA
    Org Lett; 1999 Aug; 1(4):627-30. PubMed ID: 10823190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprenoid biosynthesis in rat liver peroxisomes. Characterization of cis-prenyltransferase and squalene synthetase.
    Ericsson J; Appelkvist EL; Thelin A; Chojnacki T; Dallner G
    J Biol Chem; 1992 Sep; 267(26):18708-14. PubMed ID: 1527001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squalene synthase inhibition alters metabolism of nonsterols in rat liver.
    Keller RK
    Biochim Biophys Acta; 1996 Oct; 1303(3):169-79. PubMed ID: 8908150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification to homogeneity and some properties of squalene synthetase.
    Sasiak K; Rilling HC
    Arch Biochem Biophys; 1988 Feb; 260(2):622-7. PubMed ID: 3277535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro.
    Wasko BM; Smits JP; Shull LW; Wiemer DF; Hohl RJ
    J Lipid Res; 2011 Nov; 52(11):1957-64. PubMed ID: 21903868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation.
    Lindsey S; Harwood HJ
    J Biol Chem; 1995 Apr; 270(16):9083-96. PubMed ID: 7721822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a radiometric spot-wash assay for squalene synthase.
    Tait RM
    Anal Biochem; 1992 Jun; 203(2):310-6. PubMed ID: 1416027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squalene synthetase. Solubilization and partial purification of squalene synthetase, copurification of presqualene pyrophosphate and squalene synthetase activities.
    Kuswik-Rabiega G; Rilling HC
    J Biol Chem; 1987 Feb; 262(4):1505-9. PubMed ID: 3805037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.
    Amin D; Cornell SA; Perrone MH; Bilder GE
    Arzneimittelforschung; 1996 Aug; 46(8):759-62. PubMed ID: 9125274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.
    Ciosek CP; Magnin DR; Harrity TW; Logan JV; Dickson JK; Gordon EM; Hamilton KA; Jolibois KG; Kunselman LK; Lawrence RM
    J Biol Chem; 1993 Nov; 268(33):24832-7. PubMed ID: 8227045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity of squalene synthetase.
    Koyama T; Ogura K; Seto S
    Biochim Biophys Acta; 1980 Feb; 617(2):218-24. PubMed ID: 7357018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes.
    Bansal VS; Vaidya S
    Arch Biochem Biophys; 1994 Dec; 315(2):393-9. PubMed ID: 7986083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.
    Miki T; Kori M; Mabuchi H; Tozawa R; Nishimoto T; Sugiyama Y; Teshima K; Yukimasa H
    J Med Chem; 2002 Sep; 45(20):4571-80. PubMed ID: 12238936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amidinium cation as a mimic of allylic carbocation: synthesis and squalene synthetase inhibitory activity of an amidinium analog of a carbocation intermediate.
    Prashad M
    J Med Chem; 1993 Mar; 36(5):631-2. PubMed ID: 8496942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.